Citigroup Inc Pmv Pharmaceuticals, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Citigroup Inc holds 514,915 shares of PMVP stock, worth $829,013. This represents 0.0% of its overall portfolio holdings.

Number of Shares

514,915

Previous 515,629 0.14%

Holding current value

$829,013

Previous $835,000 8.14%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$1.44 - $1.69 $1,028 - $1,206	-714 Reduced 0.14%	514,915 $767,000
Q2 2024 Aug 12, 2024	SELL	$1.51 - $2.21 $10,711 - $15,677	-7,094 Reduced 1.36%	515,629 $835,000
Q1 2024 May 10, 2024	BUY	$1.51 - $3.12 $3,195 - $6,601	2,116 Added 0.41%	522,723 $888,000
Q4 2023 Feb 09, 2024	BUY	$1.23 - $6.6 $190,702 - $1.02 Million	155,043 Added 42.41%	520,607 $1.61 Million
Q3 2023 Nov 09, 2023	BUY	$6.01 - $8.93 $1.81 Million - $2.69 Million	301,244 Added 468.35%	365,564 $2.24 Million
Q2 2023 Aug 10, 2023	BUY	$3.94 - $6.27 $26,070 - $41,488	6,617 Added 11.47%	64,320 $402,000
Q1 2023 May 11, 2023	SELL	$4.77 - $9.16 $278,296 - $534,421	-58,343 Reduced 50.28%	57,703 $275,000
Q4 2022 Feb 09, 2023	SELL	$8.17 - $12.95 $1.2 Million - $1.9 Million	-146,864 Reduced 55.86%	116,046 $1.01 Million
Q3 2022 Nov 10, 2022	SELL	$11.4 - $17.18 $2.94 Million - $4.43 Million	-258,145 Reduced 49.54%	262,910 $3.13 Million
Q2 2022 Aug 10, 2022	BUY	$9.23 - $22.43 $4.55 Million - $11.1 Million	493,081 Added 1762.64%	521,055 $7.43 Million
Q1 2022 May 12, 2022	SELL	$14.86 - $23.55 $1.05 Million - $1.67 Million	-70,764 Reduced 71.67%	27,974 $582,000
Q4 2021 Feb 10, 2022	BUY	$19.99 - $30.24 $896,611 - $1.36 Million	44,853 Added 83.24%	98,738 $2.28 Million
Q3 2021 Nov 10, 2021	BUY	$26.84 - $36.58 $1.45 Million - $1.97 Million	53,885 New	53,885 $1.61 Million

Others Institutions Holding PMVP

# of Institutions

Shares Held

41.9M

Call Options Held

3.1K

Put Options Held

1.7K

View Full List

About PMV Pharmaceuticals, Inc.

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

More about PMVP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account